Printer Friendly

DAVSTAR FILES 510(k) DOCUMENTATION WITH FDA ON DRISTAR(R)

 NEWPORT BEACH, Calif., June 28 /PRNewswire/ -- Davstar Industries Ltd. (AMEX: DVS) today announced that it has filed with the U.S. Food and Drug Administration the documentation for its 510(k) clearance on its DriStar(R) Incontinent Management System. This documentation included the results of its clinical trial which was recently concluded. Davstar looks forward to working with the FDA to obtain final approval of the DriStar System in the United States.
 -0- 6/28/93
 /CONTACT: Roberta LeGendre of Davstar Industries, 714-852-8492/
 (DVS)


CO: Davstar Industries Ltd. ST: California IN: MTC SU: PDT

LM-JL -- LA020 -- 6345 06/28/93 14:48 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 28, 1993
Words:103
Previous Article:BREAKTHROUGH IC MEMBRANE TEST PROBE LAUNCHED BY PACKARD-HUGHES INTERCONNECT
Next Article:COMPUTER NETWORK TECHNOLOGY CORPORATION BECOMES FIRST CHANNEL NETWORKING VENDOR TO SATISFY REQUIREMENTS FOR ISO 9002 CERTIFICATION
Topics:


Related Articles
DAVSTAR INDUSTRIES ANTICIPATES MEDICARE COVERAGE OF DRISTAR SYSTEM
DAVSTAR UPDATES STATUS OF DRISTAR(TM) AND CENSLIDE(R) PRODUCTS
POTENTIAL MEDICARE REIMBURSEMENT FOR DAVSTAR'S INCONTINENT SYSTEM
DAVSTAR BEGINS FULL-SCALE PRODUCTION AND INITIAL DISTRIBUTION OF REVOLUTIONARY PATENTED CEN-SLIDE(R) URINALYSIS SYSTEM
DAVSTAR FILES FOR PATENT ON CEN-SLIDE(R) COLLECTOR CUP
UNIVERSITY TARGETS DAVSTAR'S CEN-SLIDE(R) FOR DRUG ABUSE TESTING; $500 MILLION ANNUAL MARKET TO GROW $900 MILLION BY 1995
DAVSTAR SUPPORTS FDA HIGHER CLINICAL STANDARDS
DAVSTAR RECEIVES FDA 510(k) NOTIFICATION CLEARANCE FOR DRISTAR(R)
AKSYS, LTD. ANNOUNCES 510(K) FILING OF AKSYS PHD(TM) SYSTEM ACCEPTED BY FDA FOR FORMAL REVIEW
Aksys, Ltd. Announces FDA Response to 510(K) Filing

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters